The purpose of this BAA is to renew the NIAID Adjuvant Discovery Program that supports the identification and characterization of novel, effective and safe vaccine adjuvants.
proposals to identify novel adjuvant candidates that can be used to augment the efficacy of human vaccines.
VACCINES ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE MEDIATED DISEASES Solicitation ID/Procurement Identifier: 75N93022R00009 Ultimate Completion Date: Fri Sep 29 17:00:00 GMT 2028
The contractor supplying PZP ZonaStat-H would also provide the necessary quantity of vaccine adjuvants (Freund's modified complete adjuvant for primer doses, and Freund's incomplete adjuvant for booster doses). Because the vaccine must remain frozen until within ~ 1 day of use, it must be delivered by overnight shipping method that ensures the vaccine stays frozen.
DEVELOPMENT OF MEMBRANE ANCHORED CYTOKINES AS NOVEL VACCINE ADJUVANTS FOR THE ELDERLY. Solicitation ID/Procurement Identifier: PHS20171 Ultimate Completion Date: Mon Aug 15 17:00:00 GMT 2022
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE Solicitation ID/Procurement Identifier: 75N93022R00009 Ultimate Completion Date: Fri Sep 29 17:00:00 GMT 2028
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO A HHS DESIGNATED Solicitation ID/Procurement Identifier: 75A50122D00004 Ultimate Completion Date: Fri May 21 17:00:00 GMT 2027
